When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
BPMC - Blueprint Medicines initiates U.S. application for pralsetinib
Blueprint Medicines Corporation
Blueprint Medicines (NASDAQ:BPMC) initiates its rolling NDA filing for pralsetinib (BLU-667) for RET fusion-positive non-small cell lung cancer (NSCLC). It expects to complete the submission this quarter.
More news on: Blueprint Medicines Corporation, Healthcare stocks news, Stocks on the move,